GCAC to Pursue Cannabis Joint Venture to Establish Distribution and Cultivation Hub in Portugal

Vancouver, British Columbia, Canada, August 14, 2019 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading developer of innovative data and AI technologies for the medical cannabis industry, is pleased to announce it has signed a Letter of Intent (the “LOI”) with Porto Group Global (“Porto Group”), a Portugal based private company with offices in…

Read More

Kali-Extracts Announces Cannabis Treatment For $9 Billion Epilepsy Market Under Development

Kaly1

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a treatment for epilepsy derived from the company’s patented cannabis extraction method is under research and development. “Doctors involved in research with our extracts have given me feedback that our extracts are superior to those of GW…

Read More

GREATER CANNABIS TO BEGIN CLINICAL STUDY OF CBD ABSORPTION THROUGH ITS MULTIFUNCTIONAL, MULTILAYER INTRA-ORAL DRUG DELIVERY TECHNOLOGY

GREATER CANNABIS

Study Continues To Expand, Drive Commercialization Of Company’s Eluting Patch Technology To LPs, Consumer Product And Pharmaceutical Companies BALTIMORE, MD, April 01, 2019 (GLOBE NEWSWIRE) — GREATER CANNABIS COMPANY (OTCQB: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, has announced today that it will launch a new clinical study to determine cannabidiol (CBD)…

Read More

Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina

Blueberries Medical

TORONTO, March 26, 2019 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a binding agreement effective March 25, 2019  to acquire cannabis cultivation, processing, manufacturing, export and other rights in…

Read More

Neutra Corp. Expanding Health/Wellness Capabilities into Hemp-Based Sports Performance Medicine

Neutra Corp.

Sugar Land, TX, Jan. 31, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neutra Corp. (OTCBB: NTRR) believes sports performance medicine offers an attractive, growing new market for its hemp-derived supplements, creams and other products. The company is now looking to fill a newly created role of sports performance medicine advisor to counsel Neutra Corp. on ways to deliver services to…

Read More

CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH.U) Locks Up Acquisition of In Good Health, Inc.

CLS Holdings USA, Inc.

LAS VEGAS, Jan. 16, 2019 (GLOBE NEWSWIRE) — CLS Holdings USA, Inc. “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce that it has entered into an option (the “Agreement”) to acquire In Good Health, in accordance with the previously executed letter of intent. In Good Health is a licensed medical dispensary in Brockton, Massachusetts.…

Read More